title: Persistent dysarthria after cefazolin-induced status epilepticus.
abstract: BACKGROUND
  Cefazolin is a well-known antibiotic associated with seizures. However, intrathecal cefazolin-induced status epilepticus (SE) is very rare and resultant persistent dysarthria has not been previously reported.
  
  
  METHODS
  A 66-year-old woman underwent epidural adhesiolysis due to lumbar spinal stenosis and 500 mg of cefazolin was infused through the thecal puncture site during the procedure. SE developed abruptly 40 minutes later and it persisted for 3 days. Severe dysarthria, dysphagia and cognitive dysfunction developed after the cessation of SE. Although the patient's other symptoms showed much improvement after rehabilitation, the dysarthria did not improve after intense speech therapy for 8 months. The brain MRI showed no abnormal findings, but the 2-[(18)F]fluoro-2-deoxy-D-glucose positron emission tomography ((18)F-FDG PET) of the brain demonstrated hypometabolic areas in the bilateral inferior frontal gyrus and the primary motor cortex, representing the oromotor area.
  
  
  CONCLUSIONS
  Although the exact mechanism underlying the dysarthria is unknown, the dysfunction of the inferior frontal network for speech production revealed by the brain FDG-PET, including the motor speech area (Broca's area), left insula and bilateral primary and premotor cortex representing the oromotor area, might have been responsible for the persistent dysarthria in this patient.
authors.affiliation: Department of Physical Medicine and Rehabilitation, Korea University College of Medicine, Seoul, South Korea.
authors.forename: Yuna
authors.initials: Y
authors.lastname: Lee
authors.forename: Sung-Bom
authors.initials: SB
authors.lastname: Pyun
authors.forename: Eun Kyung
authors.initials: EK
authors.lastname: Park
authors.forename: Sung Won
authors.initials: SW
authors.lastname: Youn
mesh_terms: D000368:Aged; D000767:Anesthesia, Epidural / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D002437:Cefazolin / Q000009:adverse effects*; D003072:Cognition Disorders / Q000139:chemically induced*; D004401:Dysarthria / Q000139:chemically induced*; D004569:Electroencephalography; D005260:Female; D006801:Humans; D013226:Status Epilepticus / Q000139:chemically induced*
chemical_list: D000900:Anti-Bacterial Agents; D002437:Cefazolin